Oregon Set to Receive Nearly $66 Million as Purdue and Sacklers Finalize Opioid Settlement

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement for fueling the opioid crisis, and Oregon will receive nearly $66 million over the next 15 years.

The AGs of all 55 U.S. states and territories were represented in litigation against Purdue and the Sackler family for producing and aggressively marketing opioids that fueled the largest drug crisis in the country’s history

The Settlement was Reached After Nearly a Decade of Litigation

The settlement effectively caps nearly a decade of work by attorneys general nationwide, who have pursued investigations and litigation over Purdue’s and Sackler’s role in the opioid crisis since 2016.

In a news release, Oregon Attorney General Dan Rayfield states, “The Sacklers made billions from Purdue flooding communities with opioids. This settlement holds them accountable and puts money back into the Oregon communities that paid the heaviest price.”

Following massive litigation, Purdue filed for bankruptcy in September 2019. The settlement will fund communities throughout the country, as well as individuals and groups who filed claims during the legal proceedings.

The Sackler Family Has Been Permanently Barred from Selling Opioids in the U.S.

The Sacklers have been permanently barred from selling opioids in the U.S. The agreed settlement will be distributed over the next 15 years to communities for addiction treatment, prevention, and recovery programs.

Yesterday, the Sacklers paid more than $1.5 billion, and Purdue paid $900 million. The Sacklers will also pay $500 million in May 2027, $500 million in May 2028, and $400 million in May 2029.

Purdue and the Sacklers have also been instructed to make public more than 30 million documents related to their opioid business.